HCW BIOLOGICS INC (HCWB) Stock Price, Quote, News and Overview
NASDAQ:HCWB - Nasdaq - US40423R1059 - Common Stock - Currency: USD
HCWB Quote, Performance and Key Statistics
HCW BIOLOGICS INC
NASDAQ:HCWB (1/31/2025, 8:00:01 PM)
0.2782
+0 (+1.24%)
The current stock price of HCWB is 0.2782 USD. In the past month the price decreased by -37.64%. In the past year, price decreased by -76.02%.
HCWB Latest News, Press Releases and Analysis
HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025
Dr. Hing C. Wong will speak at Genscript conference on January 15, 2025....
HCW Biologics Inc. Received NASDAQ Staff Determination Letter
Mandatory press release to disclose receipt of Nasdaq Staff Determination Letter. ...
HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules
HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules...
HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate
HCW Biologics signed license agreement with WY Biotech...
HCWB Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 18.17 | 324.98B | ||
| AMGN | AMGEN INC | 14.85 | 153.42B | ||
| GILD | GILEAD SCIENCES INC | 21.94 | 121.14B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 905.25 | 118.90B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.81 | 73.95B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.17B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.99B | ||
| BNTX | BIONTECH SE-ADR | N/A | 29.67B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.98B | ||
| NTRA | NATERA INC | N/A | 23.36B | ||
| BIIB | BIOGEN INC | 8.81 | 20.97B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 15.86B |
Related stock screener links
About HCWB
Company Profile
HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The company is headquartered in Miramar, Florida and currently employs 45 full-time employees. The company went IPO on 2021-07-20. The company is focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions such as long-haul COVID-19. The company has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth factor-β and stimulate immune cells, targeting senescent cells and the SASP factors they secrete. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, and others.
Company Info
HCW BIOLOGICS INC
2929 N Commerce Pkwy, Miramar, Fl 33025
Miramar FLORIDA US
Employees: 45
Company Website: https://hcwbiologics.com/
Investor Relations: https://investors.hcwbiologics.com/
Phone: 19548422024
HCWB FAQ
What is the stock price of HCWB?
The current stock price of HCWB is 0.2782 USD.
What is the symbol for HCW BIOLOGICS INC stock?
The exchange symbol of HCW BIOLOGICS INC is HCWB and it is listed on the Nasdaq exchange.
On which exchange is HCWB stock listed?
HCWB stock is listed on the Nasdaq exchange.
Is HCWB a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for HCWB, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of HCWB.
Does HCWB stock pay dividends?
HCWB does not pay a dividend.
What is the Price/Earnings (PE) ratio of HCWB?
HCWB does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.7).
What is the Short Interest ratio of HCWB stock?
The outstanding short interest for HCWB is 0.53% of its float.
HCWB Technical Analysis
HCWB Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to HCWB. HCWB has a bad profitability rating. Also its financial health evaluation is rather negative.
HCWB Financial Highlights
Over the last trailing twelve months HCWB reported a non-GAAP Earnings per Share(EPS) of -0.7. The EPS decreased by -66.67% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -140.57% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
HCWB Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to HCWB. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 16.94% and a revenue growth 368.22% for HCWB